1. Home
  2. OVID vs BDN Comparison

OVID vs BDN Comparison

Compare OVID & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

SELL

Current Price

$2.19

Market Cap

562.5M

Sector

Health Care

ML Signal

SELL

Logo Brandywine Realty Trust

BDN

Brandywine Realty Trust

SELL

Current Price

$2.67

Market Cap

506.3M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
OVID
BDN
Founded
2014
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
562.5M
506.3M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
OVID
BDN
Price
$2.19
$2.67
Analyst Decision
Strong Buy
Sell
Analyst Count
12
5
Target Price
★ $6.02
$3.00
AVG Volume (30 Days)
1.6M
★ 1.7M
Earning Date
11-11-2026
10-21-2026
Dividend Yield
N/A
★ 11.90%
EPS Growth
3.90
★ 9.65
EPS
★ N/A
N/A
Revenue
$7,252,000.00
★ $484,454,000.00
Revenue This Year
N/A
$12.99
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1181.27
N/A
52 Week Low
$1.18
$2.47
52 Week High
$3.11
$3.89

Technical Indicators

Market Signals
Indicator
OVID
BDN
Relative Strength Index (RSI) 34.35 28.48
Support Level $2.18 N/A
Resistance Level $2.79 $3.31
Average True Range (ATR) 0.13 0.07
MACD -0.01 -0.01
Stochastic Oscillator 11.69 8.06

Price Performance

Historical Comparison
OVID
BDN

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About BDN Brandywine Realty Trust

Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.

Share on Social Networks: